Pubmed ID: 29377373

Journal: Journal of internal medicine

Publication Date: June 1, 2018

MeSH Terms: Humans, Risk Assessment, Blood Pressure, Glomerular Filtration Rate, Renal Insufficiency, Chronic, Antihypertensive Agents

Authors: Obi Y, Kalantar-Zadeh K, Shintani A, Kovesdy CP, Hamano T

Cite As: Obi Y, Kalantar-Zadeh K, Shintani A, Kovesdy CP, Hamano T. In response to 'benefits and risks of intensive blood-pressure lowering in advanced chronic kidney disease'. J Intern Med 2018 Jun;283(6):607-610. Epub 2018 Mar 12.

Studies:

• Systolic Blood Pressure Intervention Trial (SPRINT)
• Systolic Blood Pressure Intervention Trial Primary Outcome Paper (SPRINT-POP) Data